These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

378 related items for PubMed ID: 29705691

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Evaluation of two assays for CXCL13 analysis in cerebrospinal fluid for laboratory diagnosis of Lyme neuroborreliosis.
    Henningsson AJ, Gyllemark P, Lager M, Skogman BH, Tjernberg I.
    APMIS; 2016 Nov; 124(11):985-990. PubMed ID: 27651242
    [Abstract] [Full Text] [Related]

  • 3. The recomBead Borrelia antibody index, CXCL13 and total IgM index for laboratory diagnosis of Lyme neuroborreliosis in children.
    Skogman BH, Lager M, Henningsson AJ, Tjernberg I.
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2221-2229. PubMed ID: 28730535
    [Abstract] [Full Text] [Related]

  • 4. The chemokine CXCL13 in cerebrospinal fluid in children with Lyme neuroborreliosis.
    Henningsson AJ, Lager M, Brännström R, Tjernberg I, Skogman BH.
    Eur J Clin Microbiol Infect Dis; 2018 Oct; 37(10):1983-1991. PubMed ID: 30083887
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The Usefulness of Two CXCL13 Assays on Cerebrospinal Fluid for the Diagnosis of Lyme Neuroborreliosis: a Retrospective Study in a Routine Clinical Setting.
    van Gorkom T, van Arkel GHJ, Heron M, Voet W, Thijsen SFT, Kremer K.
    J Clin Microbiol; 2021 Aug 18; 59(9):e0025521. PubMed ID: 34132584
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Discriminating between Lyme neuroborreliosis and other central nervous system infections by use of biomarkers CXCL13 and IL-6.
    Leth TA, Dessau RB, Møller JK.
    Ticks Tick Borne Dis; 2022 Sep 18; 13(5):101984. PubMed ID: 35709639
    [Abstract] [Full Text] [Related]

  • 12. CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.
    Ljøstad U, Mygland A.
    J Neurol; 2008 May 18; 255(5):732-7. PubMed ID: 18344056
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparative Analysis of the Euroimmun CXCL13 Enzyme-Linked Immunosorbent Assay and the ReaScan Lateral Flow Immunoassay for Diagnosis of Lyme Neuroborreliosis.
    Ziegler K, Rath A, Schoerner C, Meyer R, Bertsch T, Erbguth F, Bogdan C, Steinmann J, Held J.
    J Clin Microbiol; 2020 Aug 24; 58(9):. PubMed ID: 32434781
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. CXCL13 in laboratory diagnosis of Lyme neuroborreliosis-the performance of the recomBead and ReaScan CXCL13 assays in human cerebrospinal fluid samples.
    Haglund S, Lager M, Gyllemark P, Andersson G, Ekelund O, Sundqvist M, Henningsson AJ.
    Eur J Clin Microbiol Infect Dis; 2022 Jan 24; 41(1):175-179. PubMed ID: 34626256
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The predictive value of CXCL13 in suspected Lyme neuroborreliosis: a retrospective cross-sectional study.
    Knudtzen FC, Nilsson AC, Hovius JW, Skarphedinsson S.
    Eur J Clin Microbiol Infect Dis; 2020 Aug 24; 39(8):1461-1470. PubMed ID: 32172371
    [Abstract] [Full Text] [Related]

  • 20. Specificity and Diagnostic Utility of Cerebrospinal Fluid CXCL13 in Lyme Neuroborreliosis.
    Eckman EA, Clausen DM, Herdt AR, Pacheco-Quinto J, Halperin JJ.
    Clin Infect Dis; 2021 May 18; 72(10):1719-1726. PubMed ID: 32221538
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.